Overview

Pediatric MSC-AFP Sub-study for Crohn's Fistula

Status:
Recruiting
Trial end date:
2022-02-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety of using an autologous mesenchymal stromal cell (MSC) coated fistula plug in people with fistulizing Crohn's disease. Autologous means these cells to coat the plug come from the patient.
Phase:
Phase 1
Details
Lead Sponsor:
Mayo Clinic